These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9842795

  • 1. Short-term single-blind fluvoxamine treatment of pathological gambling.
    Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T.
    Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
    [Abstract] [Full Text] [Related]

  • 2. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.
    Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C.
    Biol Psychiatry; 2000 May 01; 47(9):813-7. PubMed ID: 10812040
    [Abstract] [Full Text] [Related]

  • 3. A pilot placebo-controlled study of fluvoxamine for pathological gambling.
    Blanco C, Petkova E, Ibáñez A, Sáiz-Ruiz J.
    Ann Clin Psychiatry; 2002 Mar 01; 14(1):9-15. PubMed ID: 12046642
    [Abstract] [Full Text] [Related]

  • 4. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N.
    Am J Psychiatry; 2005 Jan 01; 162(1):137-45. PubMed ID: 15625212
    [Abstract] [Full Text] [Related]

  • 5. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
    Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M.
    Clin Neuropharmacol; 2005 Jan 01; 28(1):6-10. PubMed ID: 15711432
    [Abstract] [Full Text] [Related]

  • 6. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A.
    Am J Psychiatry; 2006 Feb 01; 163(2):303-12. PubMed ID: 16449486
    [Abstract] [Full Text] [Related]

  • 7. Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
    Pallanti S, Quercioli L, Sood E, Hollander E.
    J Clin Psychiatry; 2002 Jul 01; 63(7):559-64. PubMed ID: 12143910
    [Abstract] [Full Text] [Related]

  • 8. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
    Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R.
    J Clin Psychiatry; 2002 Jun 01; 63(6):501-7. PubMed ID: 12088161
    [Abstract] [Full Text] [Related]

  • 9. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
    Pallanti S, Baldini Rossi N, Sood E, Hollander E.
    J Clin Psychiatry; 2002 Nov 01; 63(11):1034-9. PubMed ID: 12444818
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
    Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.
    J Clin Psychiatry; 2003 Jun 01; 64(6):640-7. PubMed ID: 12823077
    [Abstract] [Full Text] [Related]

  • 11. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M.
    J Clin Psychopharmacol; 2007 Dec 01; 27(6):620-4. PubMed ID: 18004130
    [Abstract] [Full Text] [Related]

  • 12. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.
    Am J Psychiatry; 1999 May 01; 156(5):756-60. PubMed ID: 10327910
    [Abstract] [Full Text] [Related]

  • 13. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.
    Goodman WK, Kozak MJ, Liebowitz M, White KL.
    Int Clin Psychopharmacol; 1996 Mar 01; 11(1):21-9. PubMed ID: 8732310
    [Abstract] [Full Text] [Related]

  • 14. Sertraline treatment of pathological gambling: a pilot study.
    Saiz-Ruiz J, Blanco C, Ibáñez A, Masramon X, Gómez MM, Madrigal M, Díez T.
    J Clin Psychiatry; 2005 Jan 01; 66(1):28-33. PubMed ID: 15669885
    [Abstract] [Full Text] [Related]

  • 15. An open-label study of citalopram in the treatment of pathological gambling.
    Zimmerman M, Breen RB, Posternak MA.
    J Clin Psychiatry; 2002 Jan 01; 63(1):44-8. PubMed ID: 11838625
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis, neurobiology, and treatment of pathological gambling.
    DeCaria CM, Hollander E, Grossman R, Wong CM, Mosovich SA, Cherkasky S.
    J Clin Psychiatry; 1996 Jan 01; 57 Suppl 8():80-3; discussion 83-4. PubMed ID: 8698687
    [Abstract] [Full Text] [Related]

  • 17. Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.
    Zheng H, Jia F, Han H, Wang S, Guo G, Quan D, Li G, Huang H.
    Eur Neuropsychopharmacol; 2019 Mar 01; 29(3):397-404. PubMed ID: 30595354
    [Abstract] [Full Text] [Related]

  • 18. Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.
    Koran LM, Chuong HW, Bullock KD, Smith SC.
    J Clin Psychiatry; 2003 Jul 01; 64(7):793-8. PubMed ID: 12934980
    [Abstract] [Full Text] [Related]

  • 19. A pilot study of impulsivity and compulsivity in pathological gambling.
    Blanco C, Potenza MN, Kim SW, Ibáñez A, Zaninelli R, Saiz-Ruiz J, Grant JE.
    Psychiatry Res; 2009 May 15; 167(1-2):161-8. PubMed ID: 19339053
    [Abstract] [Full Text] [Related]

  • 20. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
    Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E.
    J Gambl Stud; 2005 May 15; 21(4):431-43. PubMed ID: 16311876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.